scholarly journals P.150: Alpha-1 Antitrypsin Engineered Mesenchymal Stromal Cells Improves Human Islet Survival via Regulation of Macrophage Activation

2021 ◽  
Vol 105 (12S1) ◽  
pp. S62-S62
Author(s):  
Hongjun Wang
Diabetologia ◽  
2013 ◽  
Vol 57 (3) ◽  
pp. 522-531 ◽  
Author(s):  
Danielle J. Borg ◽  
Marc Weigelt ◽  
Carmen Wilhelm ◽  
Michael Gerlach ◽  
Marc Bickle ◽  
...  

Biomedicines ◽  
2021 ◽  
Vol 9 (11) ◽  
pp. 1695
Author(s):  
Rebecca P. Chow ◽  
Kevin Nguyen ◽  
Wenyu Gou ◽  
Erica Green ◽  
Katherine Morgan ◽  
...  

Chronic pancreatitis (CP) is characterized by pancreatic inflammation, fibrosis, and abdominal pain that is challenging to treat. Mesenchymal stromal cells (MSCs) overexpressing human alpha-1 antitrypsin (hAAT-MSCs) showed improved mobility and protective functions over native MSCs in nonobese diabetic mice. We investigated whether hAAT-MSCs could mitigate CP and its associated pain using trinitrobenzene sulfonic acid (TNBS)-induced CP mouse models. CP mice were given native human MSCs or hAAT-MSCs (0.5 × 106 cells/mouse, i.v., n = 6–8/group). The index of visceral pain was measured by graduated von Frey filaments. Pancreatic morphology and pancreatic mast cell count were analyzed by morphological stains. Nociceptor transient receptor potential vanilloid 1 (TRPV1) expression in dorsal root ganglia (DRG) was determined by immunohistochemistry. hAAT-MSC-treated CP mice best preserved pancreatic morphology and histology. MSC or hAAT-MSC infusion reduced abdominal pain sensitivities. hAAT-MSC therapy also suppressed TRPV1 expression in DRG and reduced pancreatic mast cell density induced by TNBS. Overall, hAAT-MSCs reduced pain and mitigated pancreatic inflammation in CP equal to MSCs with a trend toward a higher pancreatic weight and better pain relief in the hAAT-MSC group compared to the MSC group. Both MSCs and hAAT-MSCs might be used as a novel therapeutic tool for CP-related pain.


Biology ◽  
2021 ◽  
Vol 11 (1) ◽  
pp. 9
Author(s):  
Hua Wei ◽  
Erica Green ◽  
Lauren Ball ◽  
Hongkuan Fan ◽  
Jennifer Lee ◽  
...  

Extracellular vesicles (EVs) mediate many therapeutic effects of stem cells during cellular therapies. Bone marrow-derived mesenchymal stromal cells (BM-MSCs) were manufactured to overexpress the human antiprotease alpha-1 antitrypsin (hAAT) and studied to compare the EV production compared to lentivirus treated control MSCs. The goal of this study was to compare protein profiles in the EVs/exosomes of control and hAAT-MSCs using unbiased, high resolution liquid chromatography and mass spectrometry to explore differences. Nanoparticle tracking analysis (NTA) showed that the particle size of the EVs from control MSCs or hAAT-MSCs ranged from 30 to 200 nm. Both MSCs and hAAT-MSCs expressed exosome-associated proteins, including CD63, CD81, and CD9. hAAT-MSCs also expressed high levels of hAAT. We next performed proteomic analysis of EVs from three healthy donor cell lines. Exosomes collected from cell supernatant were classified by GO analysis which showed proteins important to cell adhesion and extracellular matrix organization. However, there were differences between exosomes from control MSCs and hAAT-MSCs in cytokine signaling of the immune system, stem cell differentiation, and carbohydrate metabolism (p < 0.05). These results show that hAAT-MSC exosomes contain a different profile of paracrine effectors with altered immune function, impacts on MSC stemness, differentiation, and prevention of cell apoptosis and survival that could contribute to improved therapeutic functions.


2019 ◽  
Vol 27 (8) ◽  
pp. 1436-1451
Author(s):  
Sabine Geiger ◽  
Emrah I. Ozay ◽  
Ulf Geumann ◽  
Marina K. Hereth ◽  
Terese Magnusson ◽  
...  

Stem Cells ◽  
2007 ◽  
Vol 25 (12) ◽  
pp. 3215-3222 ◽  
Author(s):  
Behrous Davani ◽  
Laertis Ikonomou ◽  
Bruce M. Raaka ◽  
Elizabeth Geras-Raaka ◽  
Russell A. Morton ◽  
...  

Diabetologia ◽  
2014 ◽  
Vol 57 (5) ◽  
pp. 1086-1086
Author(s):  
Danielle J. Borg ◽  
Marc Weigelt ◽  
Carmen Wilhelm ◽  
Michael Gerlach ◽  
Marc Bickle ◽  
...  

Author(s):  
Ahmed A. Arzouni ◽  
Andreia Vargas‐Seymour ◽  
Paramjeet K. Dhadda ◽  
Chloe L. Rackham ◽  
Guo‐Cai Huang ◽  
...  

Cytotherapy ◽  
2011 ◽  
Vol 13 (1) ◽  
pp. 19-29 ◽  
Author(s):  
Eun-Jung Jung ◽  
Song-Cheol Kim ◽  
Yu-Mee Wee ◽  
Yang-Hee Kim ◽  
Monica Young Choi ◽  
...  

2017 ◽  
Vol 131 (23) ◽  
pp. 2835-2845 ◽  
Author(s):  
Ahmed A. Arzouni ◽  
Andreia Vargas-Seymour ◽  
Chloe L. Rackham ◽  
Paramjeet Dhadda ◽  
Guo-Cai Huang ◽  
...  

Aims: The aims of the present study were (i) to determine whether the reported beneficial effects of mesenchymal stromal cells (MSCs) on mouse islet function extend to clinically relevant human tissues (islets and MSCs), enabling translation into improved protocols for clinical human islet transplantation; and (ii) to identify possible mechanisms through which human MSCs influence human islet function. Materials and methods: Human islets were co-cultured with human adipose tissue-derived MSCs (hASCs) or pre-treated with its products – extracellular matrix (ECM) and annexin A1 (ANXA1). Mouse islets were pre-treated with mouse MSC-derived ECM. Islet insulin secretory function was assessed in vitro by radioimmunoassay. Quantitative RT-PCR was used to screen human adipMSCs for potential ligands of human islet G-protein-coupled receptors. Results: We show that co-culture with hASCs improves human islet secretory function in vitro, as measured by glucose-stimulated insulin secretion, confirming previous reports using rodent tissues. Furthermore, we demonstrate that these beneficial effects on islet function can be partly attributed to the MSC-derived products ECM and ANXA1. Conclusions: Our results suggest that hASCs have the potential to improve the quality of human islets isolated for transplantation therapy of Type 1 diabetes. Furthermore, it may be possible to achieve improvements in human islet quality in a cell-free culture system by using the MSC-derived products ANXA1 and ECM.


Sign in / Sign up

Export Citation Format

Share Document